
CEO @cellchorus (dynamic single-cell functional analysis)
San Mateo, CA
Joined February 2010
- Tweets1.1K
- Following17
- Followers306
- Likes1.4K
Dan Meyer retweeted
Congrats to @sunilacharya13, @lab_rezvani & collaborators for publishing in Cancer Discovery how CD28 costimulation enhances CAR-NK cell function! CAR27 NK cells with CD28-based costimulation were ~3x more likely to exhibit serial killing. Learn more:
cellchorus.com/news/cancer-d…
Dan Meyer retweeted
In Brief This Week: Bruker, Qiagen, Prenetics, CellChorus, T2 Biosystems, More genomeweb.com/business-news/…
Dan Meyer retweeted
Attending #SITC24 this week?Be sure to check out the 𝒇𝒐𝒖𝒓 presentations featuring data from @CellChorus' single-cell analysis technology! cellchorus.com/news/four-abs…
Dan Meyer retweeted
Attending SITC 2024? Four abstracts from CellChorus and collaborators feature TIMING data! Join us to learn how dynamic single-cell analysis improves screening donors, enhancing ADCC, quantifying potency/viability, and more.
cellchorus.com/news/four-abs…
@sitcancer
Dan Meyer retweeted
Want to learn how to apply TIMING™ for potency and viability analysis in process development? Meet with us at BioProcess International in Boston Sept 25th + 26th.
Already registered? Book a meeting in the conference app:
lnkd.in/g3nu5HHS
@BioProcessIntl @InformaConnect
Dan Meyer retweeted
🚨 @IndeeLabs posted a manuscript that applies TIMING™ data from @CellChorus to show that CAR-T cells manufactured with the Indee platform have superior motility and resistance to activation-induced cell death (AICD).
biorxiv.org/content/10.1101/…
@RBerdeaux @MohsenFathi1993
Dan Meyer retweeted
💥Publication alert:
CAR T cells from individuals with complete response were enriched for migration and serial killing. Learn more about the TIMING™ data:
cellchorus.com/news/nature-c…
@NatureCancer @UH_NVLab @MohsenFathi1993 #singleCellAnalysis #CART #cellTherapy
Check out the latest articles @NatureCancer "Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling" doi.org/10.1038/s43018-024-0…
Dan Meyer retweeted
YC S21's @CellChorus has received $2.5 million in support from @ncats_nih_gov @NIH to extend its TIMING™ single-cell analysis platform that quantifies which immune cells perform best and why.
genomeweb.com/business-news/…
Wow, I only see a few dozen tickets available for @NWSL newcomer @wearebayfc's home opener against the @HoustonDash ⚽
@brandichastain @LeslieOsborne12 @daniellevslaton @SJEarthquakes @SixthStreetNews @PayPalPark @USWNT
Dan Meyer retweeted
Researchers from the @UH_NVLab at @UHouston have applied TIMING™ data to study redundancies in cytotoxic mechanisms employed by CAR T cells. See an example nanowell video below and the paper in Cell Death & Disease:
nature.com/articles/s41419-0…
#singleCell #leukemia #immunooncology
Dan Meyer retweeted
Join @CellChorus at #SLAS2024 in Boston! @RBerdeaux will present on Monday Feb 5 at 10:30 in the Precision Medicine in Immunotherapy session.
@SLAS_Org #singleCell #immunotherapy #ImmunoOncology #CarT #CarNK #antibodies
Dan Meyer retweeted
Andrew J. Last, PhD, (ECP & COO of @BioRad) has joined the CellChorus board of directors!
Learn more: cellchorus.com/news/cellchor…
Looking forward to #TCDisrupt2023! Thank you to the @TechCrunch team for recognizing the power of the @CellChorus TIMING™ platform to advance immune-cell based therapies.
Replying to @TechCrunch
@TechCrunch has selected @CellChorus as one of fewer than 50 health/bio companies for Startup Battlefield at TechCrunch Disrupt 2023! Learn more about the event and register here:
cellchorus.com/news/techcruc…
#StartupBattlefield #TCDisrupt2023
#singleCell #cellTherapy #ai #ml
Dan Meyer retweeted
.@CellChorus is a perfect example of how #tech giants are embracing the marriage between #computation and #biology. It's exciting to see!
Congrats, team, on getting into the program!
Thank you to the @NVIDIA Inception team for their support! @CellChorus applies AI to evaluate how immune cells move, interact and perform over time
cellchorus.com/news/cellchor…
#ai #artificialIntelligence #ml #machineLearning #cellTherapy #immunotherapy #immunooncology #singleCell
Dan Meyer retweeted
Thank you to the @NVIDIA Inception team for their support! @CellChorus applies AI to evaluate how immune cells move, interact and perform over time
cellchorus.com/news/cellchor…
#ai #artificialIntelligence #ml #machineLearning #cellTherapy #immunotherapy #immunooncology #singleCell
Dan Meyer retweeted
CellChorus Wins Phase I National Science Foundation SBIR Grant. The award will support development of microscale arrays for single-cell analysis in the life sciences industry. ow.ly/mzc6104Mih9
Dan Meyer retweeted
"Amid international VC decline, here's what Houston startups received investment, grant funding last quarter"
@nataliejharms and @AliceEats via @InnoMapHou
houston.innovationmap.com/q2…
#singleCell #ai #ml #immunotherapy #cellTherapy #immunoOncology
Dan Meyer retweeted
The @NIH has awarded @CellChorus (YC S21) $2.3M to scale its visual AI technology that predicts cell response to life-saving immunotherapies, enabling scientists to create new medications faster, at lower cost, and with a higher success rate.
houston.innovationmap.com/ce…
Looking forward to seeing everyone at @NYUStern for @EFrontierLabs 2023 later this week!!
We look forward to presenting at the @EFrontierLabs capstone event this Friday May 5!
Register here to attend:
endlessfrontierlabs.com/fron…
#singleCell #cellTherapy #immunotherapy @nyuniversity @NYUStern















